Alnylam Pharmaceuticals Inc
General
Total Cases20
Active Cases4
Patents340
Ratings
Experience
Grade
Trend
DCT
L2
B
PTAB
L1
C
CAFC
L1
D
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/16/25 | REDACTED VERSION of [316] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-3)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [314] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-2)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [312] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibit 1)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [310] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-5)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [308] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-2)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [306] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-3)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [304] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-10)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [302] Declaration,, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4-21)(Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [301] Statement, by BioNTech Manufacturing GmbH, BioNTech SE. (Tigan, Jeremy) (Entered: 01/16/2025) | |
| 01/16/25 | REDACTED VERSION of [300] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Tigan, Jeremy) (Entered: 01/16/2025) |